Neuropeptide levels in Dercum's disease (adiposis dolorosa).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Reumatismo

• Publication date

  2012-07-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.4081/reumatismo.2012.134PMID 22842296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management

  2012cited by this paper
• Liposuction may reduce pain in Dercum's disease (adiposis dolorosa).

  2011cited by this paper
• Lipomatosis-associated inflammation and excess collagen may contribute to lower relative resting energy expenditure in women with adiposis dolorosa

  2009cited by this paper
• Overweight and Obesity Are Associated With Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

  2008influential reference
• Role of Calcitonin Gene-Related Peptide and Substance P in Different Models of Pain

  2008influential reference
• Inhibitory effect of somatostatin on inflammation and nociception.

  2006influential reference
• Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression.

  2006influential reference
• Development of classification and response criteria for rheumatic diseases.

  2006cited by this paper
• Pain symptoms in depression: definition and clinical significance.

  2005influential reference
• Dercum's disease.

  2005cited by this paper
• Occurrence of substance P, vasoactive intestinal peptide, and calcitonin gene-related peptide in dermographism and cold urticaria

  2004influential reference
• Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women.

  2004influential reference
• The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception.

  2003influential reference
• Peripheral Blood Mononuclear Cell &bgr;-Endorphin Concentration Is Decreased in Chronic Fatigue Syndrome and Fibromyalgia but Not in Depression: Preliminary Report

  2002influential reference
• Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects

  2001cited by this paper
• Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia.

  2000influential reference
• Elevated plasma levels of neuropeptide Y in female fibromyalgia patients

  1999influential reference
• Functional somatic syndromes: one or many?

  1999cited by this paper
• Effect of raised plasma β endorphin concentrations on peripheral pain and angina thresholds in patients with stable angina

  1999influential reference
• [Dercum's disease. Fatty tissue rheumatism caused by immune defense reaction?].

  1996cited by this paper
• Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.

  1994cited by this paper
• CSF neuropeptides in cancer pain: effects of spinal opioid therapy

  1993cited by this paper
• γ2-MSH immunoreactivity in the human heart

  1989cited by this paper
• Gamma 2-MSH immunoreactivity in the human heart.

  1989cited by this paper
• Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome).

  1988influential reference
• Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively.

  1988cited by this paper
• Substance P in CSF of patients with chronic pain syndromes

  1988cited by this paper
• Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin.

  1987cited by this paper
• Beta-endorphin-immunoreactive components in human cerebrospinal fluid.

  1986cited by this paper
• Syndromes.

  1971cited by this paper

• Pain, Fear, Anxiety, and Stress: Relations to the Endogenous Opioid System.

  2024cites this paper
• Skin changes in the obese patient.

  2019cites this paper
• Dercum’s disease (adiposis dolorosa): a review of clinical presentation and management

  2019cites this paper
• Lipomatoses

  2018cites this paper
• Cutaneous manifestations of obesity and themetabolic syndrome.

  2018cites this paper
• Lipomatosen

  2018cites this paper
• Quality of life in patients with Dercum’s disease : Before and after liposuction

  2016cites this paper
• Francis Xavier Dercum: a man for all seasons

  2014cites this paper
• Morbus Dercum – Lipomatosis dolorosa: seltenes und oft übersehenes Krankheitsbild

  2013cites this paper
• Endogenous opiates and behavior: 2012.

  2013cites this paper
• Quality-of-life in patients with Dercum's disease—before and after liposuction

  2012cites this paper